Safety and Efficacy of an Oncolytic Adenovirus as an Immunotherapy for Canine Cancer Patients.
- Resource Type
- Article
- Source
- Veterinary Sciences; Jul2022, Vol. 9 Issue 7, pN.PAG-N.PAG, 16p
- Subject
TUMOR-infiltrating immune cells DERMATOPHAGOIDES pteronyssinus ADENOVIRUSES IMMUNOTHERAPY CD20 antigen SURVIVAL rate CD3 antigen DOG diseases - Language
- ISSN
- 23067381